Lenalidomide maintenance for transplant eligible and transplant ineligible newly diagnosed myeloma patients

Bookmark and Share
Published: 24 Dec 2019
Views: 109
Rating:
Save
Dr Charlotte Pawlyn - Institute of Cancer Research, London, UK

Dr Charlotte Pawlyn speaks to ecancer at the 2019 ASH meeting in Orlando on data from long-term follow up if the Myeloma XI trial which looked at the use of lenalidomide maintenance for transplant eligible and transplant ineligible newly diagnosed myeloma patients.